daniel drucker glp 1 Expanding Therapeutic Roles for GLP-1 Medications Canadian scientist wins Breakthrough Prize

In order to minimize cellular DNA damage and its consequences, there is a process in the body known as DNA-damage response (DDR)

A telehealth provider reviewing your intake should be asking about your full medication list before prescribing

Patients receiving long-term therapy with omeprazole or other proton pump inhibitors (PPIs) should be monitored for signs of B12deficiency

Typical Protocol: Common research protocols use a loading phase of roughly 4-8 mg per week (split into 2-3 subcutaneous injections) for 4-6 weeks, followed by a maintenance phase of about 2-6 mg biweekly for another 4-8 weeks, with a full cycle running 8-14 weeks and at least 4 weeks off before repeating